Middle East & Africa Intradermal Injections Market Forecast to 2028 – COVID

Middle East & Africa Intradermal Injections Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Method (Normal Sized Needle, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

Report Code : TIPRE00027990 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 23/Nov/2022

The intradermal injections market in Middle East & Africa is expected to grow from US$ 153.37 million in 2021 to US$ 302.27 million by 2028. It is estimated to grow at a CAGR of 10.2% from 2021 to 2028.

Increasing Preference for Intradermal Vaccination Fuels Market Growth

The rising acceptance of intradermal vaccination is believed to act as a major driver for the Middle East & Africa intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by vaccines, and decreases the anxiety associated with the vaccination. By developing intradermal injections, a large population can be vaccinated with comparatively lesser volumes of vaccines. The method would also help authorities in vaccinating the difficult group of population with comorbidities, as the chances of adverse events are lower than that in conventional vaccination. Intradermal vaccines against COVID-19, hepatitis A, hepatitis B, influenza, polio, measles, rabies, tetanus, yellow fever, diphtheria-tetanus-pertussis, etc., show improvement in the overall response rate, and hence, several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as already commercialized vaccines. Pfizer got approval for intradermal COVID-19 vaccines—Comirnaty—for vaccinating people of age more than 16. Therefore, the increasing preference for intradermal vaccination boosts the growth of the market in the Middle East & Africa.

Market Overview

The intradermal injections market in the Middle East & Africa is segmented into Saudi Arabia, South Africa, the UAE, and rest of Middle East & Africa. The market in this region is anticipated to grow at a CAGR 19.6% during the forecast period; this growth is attributed to the rising prevalence of various diseases and increasing funding and healthcare-related policies from governments. Saudi Arabia has a national healthcare system, wherein the government offers free medical services through different government-aided medical facilities. The private sector also plays an increasingly important role in the delivery of health care services. Saudi Arabia dominates the pharmaceutical market of the Middle East, which can be ascribed to a vast population base, and the elevating prevalence of several communicable and noncommunicable diseases. The government of Saudi Arabia is promoting and offering several incentives for the domestic manufacturing of medical devices, which, in turn, can drive the overall market growth in this country. Thus, well-developed research centers and focus on increasing research studies for the treatment of various respiratory diseases are expected to fuel the growth of the intradermal injections market in the Middle East & Africa in the coming years. The dependence of Saudi Arabia on export has reduced remarkably in the past few years, primarily due to the increasing involvement of regional players in the market. The factors such as increasing cases of tuberculosis and allergies, rising spending on healthcare, and surging number of immigrants are expected to contribute to the market in this region in the coming years.

Middle East & Africa Intradermal Injections Market Segmentation

The Middle East & Africa intradermal injections market is segmented on the basis of method, application, end user, and country.

Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further sub segmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors.

In terms of application, the Middle East & Africa intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021.

The Middle East & Africa intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021.

Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and rest of Middle East & Africa. Saudi Arabia dominated the market share in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the Middle East & Africa region.

At 10.2% CAGR, the Middle East & Africa Intradermal Injection Market is speculated to be worth US$ 302.27 million by 2028, says The Insight Partners

According to the Insight Partners’ research, the Middle East & Africa intradermal injection market was valued at US$ 153.37 million in 2021 and is expected to reach US$ 302.27 million by 2028, registering an annual growth rate of 10.2% from 2021 to 2028. Increasing incidences of diseases and increasing intradermal vaccination are the critical factors attributed to the market expansion.

During the past few years, the incidence of several communicable and non-communicable diseases has increased exponentially, which is mainly due to the unhealthy lifestyle of modern world. Smoking, infections, and genetic factors can cause serious respiratory complications, cardiovascular disorders, and bacterial and viral infections etc. are a few medical conditions exerting a huge burden on the public healthcare system in various countries. The increasing cases of cancer, tuberculosis and other allergies are expected to act as major drivers for the rapid growth of this segment. As per the data of WHO, about 10 million cases of tuberculosis are observed every year and all of them are diagnosed using tuberculin skin test involving the use of intradermal injection. Along with this, several studies concluded that the intradermal injection could improve the uptake of various cancers and immunological drugs while it can also be used to deliver the gene therapies. Further, continuously increasing cases of COVID19 is also indicating towards the future potential of this segment as various intradermal preparations are under investigation and about to get approved in near future. As the regional population is increasing continuously, the number of cases will also increase in near future, which ultimately increases the demand of intradermal injection. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products.

On the contrary, risks, complications, and dosing limitations associated with intradermal injections hurdles the growth of Middle East & Africa intradermal injection market.

Based on method, the Middle East & Africa intradermal injection market is segmented into normal sized needles, short needle, and without needle. The normal sized needles segment held 41.1%market share in 2021, amassing US$ 63.04 million. It is projected to garner US$ 119.79 million by 2028 to expand at 9.6% CAGR during 2021–2028. The normal sized needles segment is further sub segmented into intradermal microinjection, microneedle arrays, and tattoo devices. The short needle segment is further sub segmented intradermal liquid jet injectors and ballistic intradermal injectors.

Based on application, the Middle East & Africa intradermal injection market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held 31.4% market share in 2021, amassing US$ 48.19 million. It is projected to garner US$ 93.43 million by 2028 to expand at 9.9% CAGR during 2021–2028.

Based on end user, the Middle East & Africa intradermal injection market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held 43.1% market share in 2021, amassing US$ 66.06 million. It is projected to garner US$ 131.36 million by 2028 to expand at 10.3% CAGR during 2021–2028.

Based on country, the Middle East & Africa intradermal injection market has been categorized into Saudi Arabia, South Africa, UAE, and rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 43.1% market share in 2021. It was assessed at US$ 66.07 million in 2021 and is likely to hit US$ 128.64 million by 2028, exhibiting a CAGR of 10.0% during the forecast period.

Key players profiles in the Middle East & Africa intradermal injection market report are BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd, among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Intradermal Injections Market – By Method

1.3.2 MEA Intradermal Injections Market – By Application

1.3.3 MEA Intradermal Injections Market – By End User

1.3.4 MEA Intradermal Injections Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Intradermal Injections Market Landscape

4.1 Overview

4.2 MEA PEST ANALYSIS

4.2.1 Middle East and Africa PEST Analysis

4.3 EXPERT OPINIONS

5. MEA Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Intradermal Vaccination

5.1.2 Increasing Incidences of diseases

5.1.3 Rising Acceptance of Aesthetic Procedures

5.2 Key Market Restraints

5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections

5.3 Key Market Opportunities

5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries

5.4 Future Trends

5.4.1 Strategic Developments by Manufacturers

5.5 Impact Analysis of Drivers and Restraints

6. Intradermal Injections Market– MEA Analysis

6.1 MEA Intradermal Injections Market, By Country - Forecast and Analysis

7. MEA Intradermal Injections Market Revenue and Forecasts To 2028– By Method

7.1 Overview

7.2 MEA Intradermal Injections Market, By Method, 2021 & 2028 (%)

7.3 Normal-Sized Needles (MANTOUX)

7.3.1 Overview

7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)

7.4 Short Needles

7.4.1 Overview

7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.3 Intradermal Microinjection

7.4.3.1 Overview

7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.4 Microneedle Arrays

7.4.4.1 Overview

7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.5 Tattoo Devices

7.4.5.1 Overview

7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5 Without Needles

7.5.1 Overview

7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.3 Intradermal Liquid Jet Injectors

7.5.3.1 Overview

7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.4 Ballistic Intradermal Injectors

7.5.4.1 Overview

7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. MEA Intradermal Injections Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 MEA Intradermal Injections Market Share by Application - 2021 & 2028 (%)

8.3 Tuberculin Skin Testing

8.3.1 Overview

8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Allergy Testing

8.4.1 Overview

8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Local Aesthetics

8.5.1 Overview

8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)

8.6 OTHERS

8.6.1 Overview

8.6.2 Others Market Forecast and Analysis

9. MEA Intradermal Injections Market Analysis - End User

9.1 Overview

9.2 MEA Intradermal Injections Market, By End User, 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.6 OTHERS

9.6.1 Overview

9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. MEA Intradermal Injections Market Revenue and Forecasts To 2028 – Country Analysis

10.1 Middle East & Africa Intradermal Injections Market Revenue and Forecasts To 2028

10.1.1 Overview

10.1.3 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)

10.1.3.1 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.1.1 Overview

10.1.3.1.2 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.1.3 UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.1.3.1.3.1 UAE: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.1.3.2 UAE: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.1.4 UAE: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.3.1.5 UAE: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.3.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.2.1 Overview

10.1.3.2.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.2.3 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.1.3.2.3.1 Saudi Arabia: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.2.3.2 Saudi Arabia: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.2.4 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.3.2.5 Saudi Arabia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.3.1 Overview

10.1.3.3.2 South Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.1.3.3.3.1 South Africa: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.3.3.2 South Africa: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.3.4 South Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.3.3.5 South Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.3.4 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.4.1 Overview

10.1.3.4.2 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.1.3.4.3 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.1.3.4.3.1 Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.4.3.2 Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.4.4 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.3.4.5 Rest of Middle East and Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Developments

11.2.1 Overview

12. Company Profiles

12.1 BD

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 West Pharmaceutical Services, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Terumo Corporation

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 NanoPass

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Pharmajet

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Idevax

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 EUNSUNG GLOBAL

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Crossject

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Cardinal Health Inc.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Hindustan Syringes and Medical Devices Ltd

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 2. UAE: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 3. UAE: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 4. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 5. UAE: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 7. Saudi Arabia: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 8. Saudi Arabia: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 9. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 10. Saudi Arabia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. South Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 12. South Africa: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 13. South Africa: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 14. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 15. South Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 17. Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 20. Rest of Middle East and Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Developments Done by Companies

Table 22. Glossary of Terms

LIST OF FIGURES.

Figure 1. MEA Intradermal Injections Market Segmentation

Figure 2. MEA Intradermal Injections Market, By Country

Figure 3. MEA Intradermal Injections Market Overview

Figure 4. MEA Intradermal Injection Market, By Method

Figure 5. MEA Intradermal Injection Market, By Country

Figure 6. EXPERT OPINIONS

Figure 7. MEA Intradermal Injection Market Impact Analysis of Drivers and Restraints

Figure 8. MEA Intradermal Injections Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. MEA Intradermal Injections Market, by Method, 2021 & 2028 (%)

Figure 10. MEA Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11. MEA Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. MEA Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. MEA Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. MEA Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. MEA Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. MEA Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. MEA Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. MEA Intradermal Injections Market Share by Application - 2021 & 2028 (%)

Figure 19. MEA Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. MEA Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. MEA Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. MEA Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. MEA Intradermal Injections Market, by End User, 2021 & 2028 (%)

Figure 24. MEA Hospital: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. MEA Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. MEA Academic & Research Institutes: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. MEA Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Middle East & Africa Intradermal Injections Market Revenue Overview, by Country-Revenue (2021) (US$ Million)

Figure 29. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)

Figure 30. UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33. Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

The List of Companies - MEA Intradermal Injections Market

● BD

● West Pharmaceutical Services, Inc.

● Terumo Corporation

● Nanopass

● PharmaJet

● Idevax

● EUNSUNG GLOBAL

● Crossject

● Cardinal Health Inc.

● Hindustan Syringes and Medical Devices Ltd.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa intradermal injections market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP